Detalhe da pesquisa
1.
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias.
Genes Dev
; 32(11-12): 849-864, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29907650
2.
The design of guanidinium-rich transporters and their internalization mechanisms.
Adv Drug Deliv Rev
; 60(4-5): 452-72, 2008 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18164781
3.
Quantitation of cellular and topical uptake of luciferin-oligoarginine conjugates.
Methods Mol Biol
; 683: 487-504, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21053152
4.
Gateway synthesis of daphnane congeners and their protein kinase C affinities and cell-growth activities.
Nat Chem
; 3(8): 615-9, 2011 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-21778981
5.
Real-time analysis of uptake and bioactivatable cleavage of luciferin-transporter conjugates in transgenic reporter mice.
Proc Natl Acad Sci U S A
; 104(25): 10340-5, 2007 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-17563383
6.
Releasable luciferin-transporter conjugates: tools for the real-time analysis of cellular uptake and release.
J Am Chem Soc
; 128(20): 6526-7, 2006 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-16704230
7.
Molecular transporters: synthesis of oligoguanidinium transporters and their application to drug delivery and real-time imaging.
Chembiochem
; 7(10): 1497-515, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16972294